ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Biosample Name	Biosample Description	Species	Strain	Cancer Type
GSE87424	28108460	Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated byPharmacologic Targeting of the P-TEFb Complex.	Gary L. Johnson Lab	SRX2194310	GSE87424	T11 orthotopic serial transplant cell line	GSM2330626	None	T11_DMSO_24h	None	Mouse	T11_DMSO_24h	Breast_Invasive_Carcinoma_female
GSE87424	28108460	Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated byPharmacologic Targeting of the P-TEFb Complex.	Gary L. Johnson Lab	SRX2194311	GSE87424	T11 orthotopic serial transplant cell line	GSM2330627	None	T11_500nMtrametinib_24h	None	Mouse	T11_500nMtrametinib_24h	Breast_Invasive_Carcinoma_female
GSE87424	28108460	Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated byPharmacologic Targeting of the P-TEFb Complex.	Gary L. Johnson Lab	SRX2194312	GSE87424	C3TAg GEMM cell line	GSM2330628	None	C3TAgT2_DMSO_24h	None	Mouse	C3TAgT2_DMSO_24h	Breast_Invasive_Carcinoma_female
GSE87424	28108460	Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated byPharmacologic Targeting of the P-TEFb Complex.	Gary L. Johnson Lab	SRX2194313	GSE87424	C3TAg GEMM cell line	GSM2330629	None	C3TAgT2_500nMtrametinib_24h	None	Mouse	C3TAgT2_500nMtrametinib_24h	Breast_Invasive_Carcinoma_female
